References
- Statistics South Africa. Mid-year population estimates. Statistical release P0302 [Internet]. [cited 2016 Feb 3] Available from: http://www.statssa.gov.za/publications/P0302/P03022013.pdf
- Department of Health, South Africa. Regulations relating to a transparent pricing system for medicines and scheduled substances. Government Notice R1102 in Government Gazette 28214 26304. Pretoria: Department of Health; 2005
- Council for Medical Schemes. Annual Report 2014/2015 [Internet]. [cited 2016 Jul 26] Available from: http://www.medicalschemes.com/files/Annual%20Reports/AR2014_2015.pdf
- Council for Medical Schemes. Prescribed Minimum Benefits Definition [Internet]. [cited 2016 Jul 26] Available from: http://www.medicalschemes.com/medical%5Fschemes%5Fpmb/index.htm
- Discovery Health Medical Scheme. Oncology Programme. 2016. [Internet]. [cited 2016 Feb 4] Available from: https://www.discovery.co.za/discovery_coza/web/linked_content/pdfs/health/benefit_information/oncology_programme.pdf
- Carapinha JL. Policy Guidelines for Risk-Sharing Agreements in South Africa. South Afr. Fam. Pract. 2008;50(5):43–46
- Carapinha JL. Setting the Stage for Risk-Sharing Agreements: International Experiences and Outcomes-based Reimbursement. South Afr. Fam. Pract. 2008;50(4):62–65
- Department of Health. Guidelines for Pharmacoeconomic Submissions. [Internet]. South Afr. Med. Price Regist. [cited 2016 Feb 1] Available from: http://mpr.gov.za/PublishedDocuments.aspx.
- International Society for Pharmacoeconomics and Outcomes Research. Comparative Table of Pharmacoeconomic Guidelines Around The World [Internet]. [cited 2016 Feb 1] Available from: http://www.ispor.org/PEguidelines/COMP3.asp
- Eldessouki R, Dix Smith M. Health Care System Information Sharing: A Step Toward Better Health Globally. Value Health Reg. Issues. 2012;1(1):118–120
- International Society for Pharmacoeconomics and Outcomes Research. Pharmacoeconomic Guidelines Around The World [Internet]. [cited 2016 Feb 1] Available from: http://www.ispor.org/PEguidelines/index.asp
- Instituto de Evaluacion Tecnologica en Salud. Manual para la elaboracion de evaluaciones economicas en salud. Colombia. [Internet]. [cited 2016 Feb 6] Available from: http://www.iets.org.co/Manuales/Manuales/Manual%20evaluacio%CC%81n%20econo%CC%81mica%20web%2030%20sep.pdf
- Consejo de Salubridad General, Instituto Nacional de Salud Publica. Guía para la conducción de estudios de evaluación económica para la actualización del Cuadro Básico de Insumos del Sector Salud en México. Distrito Federal; Mexico; 2008
- Ministerio da Saude. Estudoes de Avaliacao Economica de Tecnologias em Saude. Brasil. [Internet]. [cited 2016 Feb 6] Available from: http://www.ispor.org/peguidelines/source/Economic-Evaluation-Guidelines-in-Brazil-Final-Version-2009.pdf
- Ministerio de Salud Publica. Guia Metodologica para la Evaluacion Economica en Salud. Cuba. 2003
- Minister of Health and Population. Guidelines for Reporting Pharmacoeconomic Evaluations. Egypt. 2013
- Ministry of Health Malaysia. Pharmacoeconomic Guideline for Malaysia. Putrajaya; 2012
- College voor zorgverzekeringen. Guidelines for pharmacoeconomic research, updated version. The Netherlands. [Internet]. [cited 2016 Feb 4] Available from: http://www.ispor.org/peguidelines/source/HTAGuidelinesNLupdated2006.pdf
- Infarmed. Guidelines for Economic Drug Evaluation Studies. Portugal. [Internet]. [cited 2016 Feb 4] Available from: http://www.ispor.org/peguidelines/source/PE%20guidelines%20in%20English_Portugal.pdf
- Health Information and Quality Authority. Guidelines for the Economic Evaluation of Health Technologies in Ireland. [Internet]. [cited 2016 Feb 5] Available from: http://www.ispor.org/peguidelines/source/Ireland_Economic_Guidelines_2010.pdf
- Taiwan Society for Pharmacoeconomic and Outcomes Research. Guidelines of Methodological Standards for Pharmacoeconomic Evaluations [Internet]. Available from: http://www.taspor.org.tw/
- Norwegian Medicines Agency. Guidelines on how to conduct pharmacoeconomic analyses. Norway. [Internet]. [cited 2016 Feb 4] Available from: http://www.ispor.org/peguidelines/source/Norwegian_guidelines2012.pdf
- Institute for Quality and Efficiency in Health Care. General Methods for the Assessment of the Relation of Benefits to Costs. Germany [Internet]. [cited 2016 Feb 5] Available from: http://www.ispor.org/peguidelines/source/Germany_AssessmentoftheRelationofBenefitstoCosts_En.pdf
- World Bank. GDP at market prices (current US$) [Internet]. [cited 2016 Feb 9] Available from: http://data.worldbank.org/indicator/NY.GDP.MKTP.CD
- Gavaza P, Rascati KL, Oladapo AO, Khoza S. The state of health economic research in South Africa: a systematic review. PharmacoEconomics. 2012;30(10):925–940.
- SAInfo. Health care in South Africa [Internet]. [cited 2016 Feb 3] Available from: http://www.southafrica.info/about/health/health.htm#.VrI-T-aOLm5
- Matsoso MP, Fryatt R. National Health Insurance: The first 18 months. S. Afr. Med. J. [Internet]. [cited 2016 Feb 16] [about 4 screens] Available from: http://hmpg.co.za/index.php/samj/article/view/3413